Skip to content

Regulatable membrane-bound IL-15 engineered TIL cell therapy for immune checkpoint inhibitor-resistant advanced melanoma: pooled analysis of phase 1 and 1/2 trials

Photo

Regulatable membrane-bound IL-15 engineered TIL cell therapy for immune checkpoint inhibitor-resistant advanced melanoma: pooled analysis of phase 1 and 1/2 trials — Engineered tumor-infiltrating cell therapy shows early signal in melanoma resistant to checkpoint inhibitors

Used in

Engineered tumor-infiltrating cell therapy shows early signal in melanoma resistant to checkpoint inhibitors en